Telesis Bio Reports First Quarter 2023 Financial Results

— Total revenue of $6.3M in 1QFY23 — BioXp® franchise revenue increased by 28% SAN DIEGO, May 11, 2023 (GLOBE NEWSWIRE) — Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today reported financial results for the first quarter of 2023. “We are pleased with our company’s performance this quarter where […]

Continue Reading